Clinical trials
Dyslipidemias trials in Taiwan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
26 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Recruiting | 7 |
| Active, not recruiting | 3 |
| Unknown status | 2 |
| Enrolling by invitation | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 6 |
| Kastle Therapeutics, LLC | 2 |
| Taipei Medical University | 2 |
| Taipei Veterans General Hospital, Taiwan | 2 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| Chang Gung Memorial Hospital | 1 |
| Chang Gung University of Science and Technology | 1 |
| Chien-Wen Hou | 1 |
| Mackay Memorial Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dyslipidemias | 26 |
| Hypercholesterolemia | 9 |
| Hyperlipidemias | 7 |
| Obesity | 6 |
| Diabetes Mellitus | 5 |
| Hypertension | 5 |
| Cardiovascular Diseases | 4 |
| Hyperlipoproteinemia Type II | 4 |
| Metabolic Syndrome | 4 |
| Homozygous Familial Hypercholesterolemia | 3 |
Trials
Showing 26 to 26 of 26. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.